Stockscreener 앱 받기
32.10
1.71%
0.54
시장 영업 전:
32.00
-0.10
-0.31%
전일 마감가:
$31.56
열려 있는:
$31.14
하루 거래량:
1.43M
Relative Volume:
1.01
시가총액:
$4.17B
수익:
-
순이익/손실:
$-507.65M
주가수익비율:
-6.9783
EPS:
-4.6
순현금흐름:
$-616.24M
1주 성능:
+5.07%
1개월 성능:
-2.79%
6개월 성능:
-55.48%
1년 성능:
-70.86%
1일 변동 폭
$30.89
$32.32
1주일 범위
$30.32
$32.32
52주 변동 폭
$27.66
$121.06
백스사이트 Stock (PCVX) Company Profile
명칭
Vaxcyte Inc
전화
650-837-0111
주소
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
32.10 | 4.10B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
백스사이트 Stock (PCVX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-20 | 개시 | Goldman | Buy |
| 2023-12-07 | 개시 | Mizuho | Buy |
| 2023-04-18 | 개시 | TD Cowen | Outperform |
| 2023-01-03 | 재확인 | Needham | Buy |
| 2022-12-15 | 개시 | Guggenheim | Buy |
| 2022-11-17 | 개시 | BTIG Research | Buy |
| 2021-12-29 | 재개 | Jefferies | Buy |
| 2021-06-24 | 재개 | Jefferies | Buy |
| 2020-07-07 | 개시 | BofA Securities | Buy |
| 2020-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 개시 | Needham | Buy |
모두보기
백스사이트 주식(PCVX)의 최신 뉴스
How to forecast Vaxcyte Inc. trends using time seriesPortfolio Return Summary & Daily Entry Point Trade Alerts - Newser
Vaxcyte Says VAX-31 Pneumococcal Disease Study Advances to Final Stage - MarketScreener
Vaxcyte advances VAX-31 pneumococcal vaccine to final stage of infant study - Investing.com
Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose - GlobeNewswire
92% Disease Coverage: Vaxcyte's VAX-31 Could Become Broadest Pneumococcal Vaccine for Infants - Stock Titan
What recovery options are there for Vaxcyte Inc.2025 Top Gainers & High Conviction Investment Ideas - Newser
How to build a custom watchlist for Vaxcyte Inc.July 2025 Update & Community Supported Trade Ideas - Newser
Will Vaxcyte Inc. stock recover after earningsPortfolio Performance Summary & AI Enhanced Trading Alerts - khodrobank.com
Evaluating Vaxcyte Inc. with trendline analysisWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
How institutional ownership impacts Vaxcyte Inc. stockMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
What is the target price for Vaxcyte Inc. stock2025 Trading Volume Trends & Trade Opportunity Analysis Reports - khodrobank.com
Short interest data insights for Vaxcyte Inc.Volume Spike & Reliable Entry Point Alerts - Newser
How to interpret RSI for Vaxcyte Inc. stockWeekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
Multi factor analysis applied to Vaxcyte Inc.Trade Volume Summary & Risk Controlled Stock Pick Alerts - Newser
Vaxcyte Inc. stock outlook for YEARPortfolio Performance Summary & Consistent Growth Equity Picks - Newser
What indicators show strength in Vaxcyte Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
How to manage a losing position in Vaxcyte Inc.July 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Is Vaxcyte Inc. forming a bottoming baseWeekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
Analyzing Vaxcyte Inc. with risk reward ratio chartsPortfolio Update Report & Weekly High Conviction Trade Ideas - Newser
Is Vaxcyte Inc. stock good for income investorsWeekly Earnings Recap & Weekly Momentum Picks - khodrobank.com
Market Wrap: Can Vaxcyte Inc. expand its profit marginsPortfolio Risk Report & Reliable Trade Execution Plans - khodrobank.com
Is Vaxcyte Inc. in a bullish channelQuarterly Portfolio Review & Safe Capital Growth Tips - khodrobank.com
Is Vaxcyte Inc. stock reversal real or fakeTrade Analysis Summary & Weekly Market Pulse Updates - Newser
Vaxcyte Inc. stock trend forecast2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
Insider Sell: What is the PEG ratio of Vaxcyte Inc.July 2025 Spike Watch & Consistent Return Investment Signals - khodrobank.com
What is the long term forecast for Vaxcyte Inc. stock2025 Sector Review & Growth Focused Investment Plans - khodrobank.com
Risk vs reward if holding onto Vaxcyte Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - Newser
InvestingPro’s Fair Value model predicted Vaxcyte’s 46% decline By Investing.com - Investing.com
Visualizing Vaxcyte Inc. stock with heatmapsShort Setup & Long Hold Capital Preservation Plans - Newser
Full technical analysis of Vaxcyte Inc. stockTrade Risk Summary & Reliable Entry Point Trade Alerts - Newser
Market Outlook: How does Vaxcyte Inc. compare to its peersQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - khodrobank.com
Momentum Shift: What are Vaxcyte Inc.’s recent SEC filings showing2025 Big Picture & Low Drawdown Trading Strategies - khodrobank.com
Is Vaxcyte Inc. vulnerable to short sellersTrade Volume Summary & Low Drawdown Investment Strategies - khodrobank.com
Advanced analytics toolkit walkthrough for Vaxcyte Inc.2025 Bull vs Bear & Comprehensive Market Scan Reports - Newser
Can Vaxcyte Inc. Regain Lost Ground This Quarter getLinesFromResByArray error: size == 0 - kangso.co.kr
Published on: 2025-08-31 17:30:01 - Newser
Reversal indicators forming on Vaxcyte Inc. stockJuly 2025 Decliners & Reliable Momentum Entry Alerts - Newser
Is Vaxcyte Inc. forming a reversal patternJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - Newser
Using data models to predict Vaxcyte Inc. stock movementJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
How to track smart money flows in Vaxcyte Inc.Exit Point & Consistent Return Investment Signals - Newser
백스사이트 (PCVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
백스사이트 주식 (PCVX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PRESIDENT AND CFO |
Apr 07 '25 |
Option Exercise |
20.93 |
4,777 |
99,983 |
131,950 |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER |
Apr 04 '25 |
Option Exercise |
8.96 |
20,533 |
183,888 |
518,775 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Option Exercise |
21.41 |
5,000 |
107,050 |
46,620 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Sale |
70.74 |
5,000 |
353,699 |
41,620 |
1.14%
1.34%
자본화:
|
볼륨(24시간):